PHARMA detailing
50 views | +0 today
Follow
Your new post is loading...
Your new post is loading...
Rescooped by Orlando Bordignon from Veille Pharma
Scoop.it!

Le visiteur médical connecté - Nouvelle enquête EuroStaf Juin 2013

Dans un contexte inédit de retournement du marché et de contraintes réglementaires croissantes, les laboratoires pharmaceutiques doivent repenser leur stratégie produit et faire évoluer en profondeur les modes de communication et d’information à destination des professionnels de santé.

 

Les visiteurs médicaux sont les premiers exposés à ces mutations.
Pour faire la différence sur ce marché hautement concurrentiel, les laboratoires déploient actuellement de nouveaux outils digitaux qui ont vocation à optimiser l’efficacité commerciale de la visite médicale. Le Remote detailing, les e-ADV ou le Close Loop Marketing sont quelques-uns des leviers digitaux choisis au service du « visiteur médical connecté ».


Via Dominique Godefroy, Fabrice Vezin, Alexandre DUBOIS
more...
No comment yet.
Rescooped by Orlando Bordignon from Pharma Communication & Social Media
Scoop.it!

iPad detailing: still room for pharma to improve - PMLiVE

iPad detailing: still room for pharma to improve - PMLiVE | PHARMA detailing | Scoop.it

Although iPads are firmly in the mainstream when it comes to pharma detailing, they could be used more effectively, according to a new study. Manhattan Research says that having embarked on massive technology roll-out programmes, the challenge the industry now faces is how to use the technology in a way that engages doctors and adds value to sales reps' detailing time. Manhattan Research's VP of research Monique Levy said: “In the three years since the iPad's debut, pharmaceutical firms have put tablets in the hands of nearly all of their sales representatives. “The challenge now lies in creating compelling content and crystalising learning moments that physicians expect and the devices excel at.” The analysts' new ePharma Physician 2013 study highlighted using animations and video to illustrate a novel mechanism of action (MOA) or treatment pathway as particular areas where the industry can provide 'Ah-hah!' moments.


Via Dinesh Chindarkar
more...
eMedToday's curator insight, August 6, 2013 8:48 PM

This is the key issue for Pharma digital marketing

 

Manhattan Research says that having embarked on massive technology roll-out programmes, the challenge the industry now faces is how to use the technology in a way that engages doctors and adds value to sales reps' detailing time.

 

Manhattan Research's VP of research Monique Levy said: “In the three years since the iPad's debut, pharmaceutical firms have put tablets in the hands of nearly all of their sales representatives.

 

“The challenge now lies in creating compelling content and crystalising learning moments that physicians expect and the devices excel at.”

Rescooped by Orlando Bordignon from Pharma Communication & Social Media
Scoop.it!

A Comprehensive Overview of How Games Help Healthcare in 2013 - GCo

A Comprehensive Overview of How Games Help Healthcare in 2013 - GCo | PHARMA detailing | Scoop.it

Gamification and healthcare may be the next best thing since the invention of bread and butter. I recently read an article on 3 different ways that video games can improve health and immediately became curious as to other research going on in this area. Since GSummit 2013 is fast approaching, I would like to take the time to provide a brief comprehensive overview of how games and healthcare are converging in harmony in 2013.


Via Dinesh Chindarkar
more...
No comment yet.
Rescooped by Orlando Bordignon from Digital marketing pharma
Scoop.it!

Will eDetailing work for drug companies ?

Will eDetailing work for drug companies ? | PHARMA detailing | Scoop.it
Based on a comScore longitudinal study of a permission-based panel of 1,000 U.S. physicians HCP Content websites such as Medscape.com, which provide content or services catering specifically to phy...

Via Olivier Delannoy
more...
eMedToday's curator insight, May 30, 2013 7:37 AM

yes, if

 

 "Ensure that the detail offers information that the physician finds valuable .  This includes not only information about the medication but information about patient outcomes and insurance coverage.

 

 Answer the questions without referring the question to a medical liaison – If physicians have a question they want it answered and don’t want to hear that “we’ll have to get back to you “.

 

 Ensure that the information is not biased but is transparent – This means opening up clinical trial information on the product".